{"id":20294,"date":"2022-09-30T08:02:52","date_gmt":"2022-09-30T12:02:52","guid":{"rendered":"https:\/\/medicarereport.org\/?p=20294"},"modified":"2022-09-30T08:02:54","modified_gmt":"2022-09-30T12:02:54","slug":"pharma-funded-fda-gets-drugs-out-faster-but-some-work-only-marginally-and-most-are-pricey","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=20294","title":{"rendered":"Pharma-Funded FDA Gets Drugs Out Faster, But Some Work Only \u2018Marginally\u2019 and Most Are Pricey"},"content":{"rendered":"\n<p>(By Arthur Allen for Kaiser Health News) <\/p>\n\n\n\n<p>Dr. Steven-Huy Han, a UCLA liver specialist, has prescribed Ocaliva to a handful of patients, although he\u2019s not sure it helps.<\/p>\n\n\n\n<p>As advertised, the drug is lowering levels of an enzyme called alkaline phosphatase in their blood, and that should be a sign of healing for their autoimmune disease, called primary biliary cholangitis. But \u201cno one knows for sure,\u201d Han said, whether less enzyme means they won\u2019t get liver cancer or cirrhosis in the long run.<\/p>\n\n\n\n<p>\u201cI have no idea if the drug will make them better,\u201d he said. \u201cIt could take 10, 20, or 30 years to know. Continue reading <a href=\"https:\/\/khn.org\/news\/article\/pharma-fda-drugs-accelerated-approval-marginally-effective-expensive\/\" data-type=\"URL\" data-id=\"https:\/\/khn.org\/news\/article\/pharma-fda-drugs-accelerated-approval-marginally-effective-expensive\/\">here&#8230;<\/a><\/p>\n\n\n\n<p>Kaiser Health News is a non profit national health policy news service that is part of the nonpartisan Henry J. Kaiser Family Foundation.<\/p>\n\n\n\n<p><img loading=\"lazy\" decoding=\"async\" width=\"175\" height=\"91\" class=\"wp-image-899\" style=\"width: 175px;\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1.png\" alt=\"\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1.png 1600w, https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1-300x156.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1-1024x533.png 1024w, https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1-390x205.png 390w\" sizes=\"auto, (max-width: 175px) 100vw, 175px\" \/><\/p>\n\n\n\n<p class=\"has-small-font-size\"><strong>Notice:<\/strong>&nbsp;The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Arthur Allen for Kaiser Health News) Dr. Steven-Huy Han, a UCLA liver specialist, has prescribed Ocaliva to a handful<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31,15],"tags":[76,146,147],"class_list":["post-20294","post","type-post","status-publish","format-standard","hentry","category-fda","category-part-dprescription-drugs","tag-fda","tag-fdas-accelerated-approval","tag-pharmaceutical"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/20294","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=20294"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/20294\/revisions"}],"predecessor-version":[{"id":20295,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/20294\/revisions\/20295"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=20294"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=20294"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=20294"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}